Korea’s Bukwang To Sell Hepatitis B Drug In Philippines, Plans Launches In U.S., Europe   

SEOUL - South Korea's Bukwang Pharmaceutical will begin selling its chronic hepatitis B drug Levovir (clevudine) in the Philippines in June, and plans to eventually launch the product across Asia, the U.S. and Europe, according to a company executive

More from Archive

More from Scrip